Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

Current Research Studies

Noninvasive Biomarkers of Hepatic Fibrosis in Urea Cycle Disorders

UCDC Liver Study

Condition: Genetics
Clinicaltrials.gov ID: NCT04612764

What is the goal of the study?

Primary Study Objective: To assess risk for increased fibrosis using serum biomarkers and/or patented vibration-controlled transient elastography technology (VCTE using Fibroscan®) in distal disorders (argininosuccinate synthetase deficiency or ASS1D, argininosuccinate lyase deficiency or ASLD, and arginase deficiency or ARG1D) as compared to ornithine transcarbamylase deficiency (OTCD)

Who can participate in the study?

Please contact the study team listed below to learn more.

Study Team:

PI (Study Doctor): Christina Lam
Study Team Member: Hayden Vreugdenhil, Hayden.Vreugdenhil@seattlechildrens.org

Seattle Children’s complies with applicable federal and other civil rights laws and does not discriminate, exclude people or treat them differently based on race, color, religion (creed), sex, gender identity or expression, sexual orientation, national origin (ancestry), age, disability, or any other status protected by applicable federal, state or local law. Financial assistance for medically necessary services is based on family income and hospital resources and is provided to children under age 21 whose primary residence is in Washington, Alaska, Montana or Idaho.